Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 12:38 AM
NCT ID:
NCT01551667
Brief Summary:
The primary objective of this study is to detect differences in anti-S. aureus antibody assays (IgM, IgA, IgG and its subclasses) between (1) a group of patients with bacteremia due to a chronic wound (cases) and (2) a group of patients with localized chronic wound infections (control).
Detailed Description:
Secondary objectives include:
* To propose a diagnostic marker of bacteraemia based on the detection of anti-S. aureus by xMAP technology
* To evaluate the kinetics of the humoral immune response to S. aureus in patients with bacteraemia
* To evaluate the virulence of S. aureus isolated from chronic, infected wounds
* To enrich the Nîmes University Hospital biobank
* To evaluate the prevalence of different antibodies within each group
Study:
NCT01551667
Study Brief:
Protocol Section:
NCT01551667